Obligatory and facilitative allelic variation in the DNA methylome within common disease-associated loci
0301 basic medicine
570
Genome, Human
Science
Q
610
Genetic Variation
High-Throughput Nucleotide Sequencing
DNA Methylation
Polymorphism, Single Nucleotide
Article
Epigenesis, Genetic
03 medical and health sciences
Haplotypes
Risk Factors
MD Multidisciplinary
Humans
CpG Islands
Disease
Genetic Predisposition to Disease
Alleles
Genome-Wide Association Study
DOI:
10.1038/s41467-017-01586-1
Publication Date:
2017-12-27T11:38:31Z
AUTHORS (12)
ABSTRACT
AbstractIntegrating epigenetic data with genome-wide association study (GWAS) results can reveal disease mechanisms. The genome sequence itself also shapes the epigenome, with CpG density and transcription factor binding sites (TFBSs) strongly encoding the DNA methylome. Therefore, genetic polymorphism impacts on the observed epigenome. Furthermore, large genetic variants alter epigenetic signal dosage. Here, we identify DNA methylation variability between GWAS-SNP risk and non-risk haplotypes. In three subsets comprising 3128 MeDIP-seq peripheral-blood DNA methylomes, we find 7173 consistent and functionally enriched Differentially Methylated Regions. 36.8% can be attributed to common non-SNP genetic variants. CpG-SNPs, as well as facilitative TFBS-motifs, are also enriched. Highlighting their functional potential, CpG-SNPs strongly associate with allele-specific DNase-I hypersensitivity sites. Our results demonstrate strong DNA methylation allelic differences driven by obligatory or facilitative genetic effects, with potential direct or regional disease-related repercussions. These allelic variations require disentangling from pure tissue-specific modifications, may influence array studies, and imply underestimated population variability in current reference epigenomes.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (76)
CITATIONS (100)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....